Foged et al., 1987 - Google Patents
Characterization and biological effects of the Pasteurella multocida toxinFoged et al., 1987
- Document ID
- 2545942336453461263
- Author
- Foged N
- Pedersen K
- Elling F
- Publication year
- Publication venue
- FEMS microbiology letters
External Links
Snippet
A proteinaceous substance produced by a toxigenic type D strain of Pasteurella multocida was purified by anion exchange chromatography and preparative polyacrylamide gel electrophoresis (PAGE). The protein, the P. multocida toxin (PMT), had a molecular weight of …
- 230000004071 biological effect 0 title description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Foged et al. | Characterization and biological effects of the Pasteurella multocida toxin | |
| Elsbach et al. | Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. | |
| Nagai et al. | Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG | |
| US4761471A (en) | Bone morphogenetic protein composition | |
| US4619989A (en) | Bone morphogenetic protein composition | |
| Molla et al. | Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture | |
| US6211148B1 (en) | Antimicrobial peptides from bovine neutrophis | |
| KR860000842B1 (en) | A method for stabilizing a tumor nectrosis factor | |
| Kothary et al. | Purification and characterization of an extracellular cytolysin produced by Vibrio damsela | |
| US5874079A (en) | Method for killing gram positive bacteria with isolated type II phospholipase A2 | |
| US4355104A (en) | Bacteriolytic proteins | |
| US4520016A (en) | Bacteriolytic proteins | |
| US20050064546A1 (en) | Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms | |
| Worthington et al. | Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation | |
| AU622102B2 (en) | A pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4 | |
| FR2623400A1 (en) | FACTOR OF ACTIVATION OF NEUTROPHILES | |
| US4714674A (en) | Chemotactic assay for immunogenicity | |
| Fritz et al. | [74] Proteinase inhibitors from boar seminal plasma | |
| Schengrund et al. | Ganglioside‐induced adherence of botulinum and tetanus neurotoxins to adducin | |
| Lopez-Merino et al. | Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances | |
| JPH07505787A (en) | Polypeptides obtainable from Faschiola sp., vaccines, treatments and their DNA sequences | |
| Chien-chyou et al. | Biosynthesis and partial characterization of tear film glycoproteins. Incorporation of radioactive precursors by human lacrimal gland explants in vitro | |
| Cotter et al. | Purification and characterisation of an ‘elastase-like’enzyme from rabbit polymorphonuclear leucocytes | |
| JPH0730114B2 (en) | Inhibin | |
| Liberda et al. | D-fructose-binding proteins in bull seminal plasma: isolation and characterization |